Strategy Asset Managers LLC grew its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,911 shares of the financial services provider’s stock after purchasing an additional 147 shares during the period. Strategy Asset Managers LLC’s holdings in Aflac were worth $508,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of the stock. Private Trust Co. NA raised its stake in Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares in the last quarter. Phillips Wealth Planners LLC grew its stake in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after buying an additional 100 shares during the last quarter. Raleigh Capital Management Inc. raised its stake in shares of Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 100 shares during the last quarter. TKG Advisors LLC grew its position in Aflac by 0.5% during the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock worth $2,230,000 after acquiring an additional 103 shares during the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its position in Aflac by 1.6% in the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after purchasing an additional 107 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Stock Report on Aflac
Aflac Stock Down 1.0 %
Shares of NYSE AFL opened at $109.71 on Friday. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a market cap of $59.88 billion, a P/E ratio of 11.43, a P/E/G ratio of 3.24 and a beta of 0.93. The firm has a 50 day moving average price of $106.49 and a 200 day moving average price of $107.66.
Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Analysts expect that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- Differences Between Momentum Investing and Long Term Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
- What Are Dividend Contenders? Investing in Dividend Contenders
- Affirm Strikes Back: Can a New Deal Mitigate the Recent Loss?
- What is a SEC Filing?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.